Debridement, antibiotics and implant retention for prosthetic joint infection: comparison of outcomes between total hip arthroplasty and hip resurfacing
暂无分享,去创建一个
[1] B. Füchtmeier,et al. Factors associated with infection recurrence after two-stage exchange for periprosthetic hip infection , 2022, International Orthopaedics.
[2] J. Epinette,et al. French Hip Resurfacing Registry: A Study of 1650 Cases. , 2021, Orthopaedics & traumatology, surgery & research : OTSR.
[3] S. Odum,et al. Complications in the treatment of prosthetic joint infection. , 2020, The bone & joint journal.
[4] J. Pritchett. Decision Matrix-Guided Treatment of Infected Hip Resurfacing. , 2020, Journal of long-term effects of medical implants.
[5] K. Smulders,et al. Severe Obesity Increases Risk of Infection After Revision Total Hip Arthroplasty. , 2019, The Journal of arthroplasty.
[6] A. Liddle,et al. Implant materials and prosthetic joint infection: the battle with the biofilm , 2019, EFORT open reviews.
[7] R. D. de Steiger,et al. Orthopaedic registries: the Australian experience , 2019, EFORT open reviews.
[8] F. Haddad,et al. Outcomes of repeat two-stage exchange hip arthroplasty for prosthetic joint infection. , 2019, The bone & joint journal.
[9] J. Kärrholm,et al. Similar Risk of Re-Revision in Patients after One- or Two-Stage Surgical Revision of Infected Total Hip Arthroplasty: An Analysis of Revisions in the Swedish Hip Arthroplasty Register 1979–2015 , 2019, Journal of clinical medicine.
[10] J. Jenny,et al. The CRIOAc healthcare network in France: A nationwide Health Ministry program to improve the management of bone and joint infection. , 2019, Orthopaedics & traumatology, surgery & research : OTSR.
[11] B. Springer,et al. The prevention of infection: 12 MODIFIABLE RISK FACTORS , 2019, The bone & joint journal.
[12] R. Cooney,et al. Impact of ASA score misclassification on NSQIP predicted mortality: a retrospective analysis , 2017, Perioperative Medicine.
[13] D. Berry,et al. Irrigation and Debridement with Component Retention for Acute Infection After Hip Arthroplasty: Improved Results with Contemporary Management , 2017, The Journal of bone and joint surgery. American volume.
[14] W. Ding,et al. Risk factors for periprosthetic joint infection following primary total hip or knee arthroplasty: a meta‐analysis , 2017, International wound journal.
[15] J. M. Gómez-Palomo,et al. The Kidney, Liver, Index surgery and C reactive protein score is a predictor of treatment response in acute prosthetic joint infection , 2017, International Orthopaedics.
[16] D. Bohl,et al. Incidence, Risk Factors, and Sources of Sepsis Following Total Joint Arthroplasty. , 2016, The Journal of arthroplasty.
[17] K. Kaye,et al. Surgical Site Infections Following Birmingham Hip Resurfacing , 2016, Infection Control & Hospital Epidemiology.
[18] É. Drumez,et al. Excellent short-term results of hip resurfacing in a selected population of young patients. , 2015, Orthopaedics & traumatology, surgery & research : OTSR.
[19] J. Bosco,et al. The Otto Aufranc Award: Modifiable versus Nonmodifiable Risk Factors for Infection After Hip Arthroplasty , 2015, Clinical orthopaedics and related research.
[20] S. McMahon,et al. Survivorship and clinical outcome of Birmingham hip resurfacing: a minimum ten years’ follow-up , 2015, International Orthopaedics.
[21] J. Calhoun,et al. Biofilms in periprosthetic orthopedic infections. , 2014, Future microbiology.
[22] P. Pynsent,et al. Survival and functional outcome of the Birmingham Hip Resurfacing system in patients aged 65 and older at up to ten years of follow-up , 2014, International Orthopaedics.
[23] J. Kärrholm,et al. Increasing risk of prosthetic joint infection after total hip arthroplasty , 2012, Acta orthopaedica.
[24] M. Titécat,et al. Evaluation of rapid mecA gene detection versus standard culture in staphylococcal chronic prosthetic joint infections. , 2012, Diagnostic microbiology and infectious disease.
[25] J. Ariza,et al. Early prosthetic joint infection: outcomes with debridement and implant retention followed by antibiotic therapy. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[26] J. Parvizi,et al. New Definition for Periprosthetic Joint Infection: From the Workgroup of the Musculoskeletal Infection Society , 2011, Clinical orthopaedics and related research.
[27] S. Klouche,et al. Infected total hip arthroplasty treated by an irrigation-debridement/component retention protocol. A prospective study in a 12-case series with minimum 2 years' follow-up. , 2011, Orthopaedics & traumatology, surgery & research : OTSR.
[28] Y.H. Kim,et al. Cementless revision for infected total hip replacements. , 2011, The Journal of bone and joint surgery. British volume.
[29] Peter A Cameron,et al. Incidence and risk factors for deep surgical site infection after primary total hip arthroplasty: a systematic review. , 2010, The Journal of arthroplasty.
[30] Elhadi Sariali,et al. Total hip arthroplasty revision due to infection: a cost analysis approach. , 2010, Orthopaedics & traumatology, surgery & research : OTSR.
[31] J. Parvizi,et al. Revision Hip Arthroplasty: Infection is the Most Common Cause of Failure , 2010, Clinical orthopaedics and related research.
[32] S. Kurtz,et al. Prosthetic joint infection risk after total hip arthroplasty in the Medicare population. , 2009, The Journal of arthroplasty.
[33] S. Kurtz,et al. Future Young Patient Demand for Primary and Revision Joint Replacement: National Projections from 2010 to 2030 , 2009, Clinical orthopaedics and related research.
[34] B. Jolles,et al. Cross-cultural adaptations of the Oxford-12 HIP score to the French speaking population. , 2009, Orthopaedics & traumatology, surgery & research : OTSR.
[35] S. Kurtz,et al. Infection burden for hip and knee arthroplasty in the United States. , 2008, The Journal of arthroplasty.
[36] B. Shadbolt,et al. Quality of Life after Infection in Total Joint Replacement , 2008, Journal of orthopaedic surgery.
[37] A. Hart,et al. The effect of metal ions in solution on bacterial growth compared with wear particles from hip replacements. , 2007, The Journal of bone and joint surgery. British volume.
[38] E. Bohm,et al. Presence of medical comorbidities in patients with infected primary hip or knee arthroplasties. , 2007, The Journal of arthroplasty.
[39] J. Mandrekar,et al. Outcome of prosthetic joint infections treated with debridement and retention of components. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[40] C. Bouchard,et al. Familial risk of overweight and obesity in the Canadian population using the WHO/NIH criteria. , 2000, Obesity research.
[41] P. McLardy-Smith,et al. Prosthetic joint infection , 1999, Current infectious disease reports.
[42] B. Morrey,et al. Treatment of Infection with Débridement and Retention of the Components following Hip Arthroplasty* , 1998, The Journal of bone and joint surgery. American volume.